About this trial
The purpose of this registry is to (A) better describe the incidence and prevalence of Amyotrophic Lateral Sclerosis (ALS) in the United States;(B) examine appropriate factors, such as environmental and occupational, that may be associated with the disease; (C) better outline key demographic factors (such as age, race or ethnicity, gender, and family history of individuals who are diagnosed with the disease) associated with the disease; and (D) better examine the connection between ALS and other motor neuron disorders that can be confused with ALS, misdiagnosed as ALS, and in some cases progress to ALS.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
ALS cases in the United States
Trial design
Other
Other
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
The National Amyotrophic Lateral Sclerosis (ALS) Registry
To determine the incidence and prevalence of Amyotrophic Lateral Sclerosis in the US.
Secondary outcomes
Risk factors of ALS
To learn more about the potential risk factors for ALS
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Centers for Disease Control and Prevention
Lead sponsor
US Department of Veterans Affairs
Collaborator
Centers for Medicare and Medicaid Services
Collaborator